Science Explorer Back to mapMap
Discussion
Company · Lisbon · ??

LEO Farmacêuticos (Portugal)

Research works
17
▼ 13% vs 2018-21
Citations
596
35.0 per fractional work
Top-10% rate
4.3%
all institutions 10.0%
Open access
31%
world 40%
International
42%
world 18%

Not ranked overall: LEO Farmacêuticos (Portugal) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does LEO Farmacêuticos (Portugal) work in?

In all years, 46% of research at LEO Farmacêuticos (Portugal) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (44%), Biochemistry, Genetics and Molecular Biology (20%), Pharmacology, Toxicology and Pharmaceutics (7%). It does 1.7× the world's share of Life Sciences.

Health Sciences: 8 fractional works · 45.7% of its workMedicine: 7 fractional works · 43.6% of its workDermatology: 1 fractional works · 7.1% of its workOncology: 1 fractional works · 6.3% of its workPharmacology: 1 fractional works · 6.2% of its workPathology and Forensic Medicine: 1 fractional works · 3.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 2.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.8% of its workNephrology: 0 fractional works · 1.6% of its workPsychiatry and Mental health: 0 fractional works · 1.6% of its workPhysiology: 0 fractional works · 1.3% of its workSurgery: 0 fractional works · 1.1% of its workAnesthesiology and Pain Medicine: 0 fractional works · 1.0% of its workEpidemiology: 0 fractional works · 1.0% of its workImmunology and Allergy: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.0% of its workNeurology: 0 fractional works · 0.6% of its workComplementary and alternative medicine: 0 fractional works · 0.5% of its workOphthalmology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 1.6% of its workGeneral Health Professions: 0 fractional works · 1.0% of its workComplementary and Manual Therapy: 0 fractional works · 0.6% of its workNursing: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.5% of its workLife Sciences: 6 fractional works · 36.5% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 20.0% of its workMolecular Biology: 2 fractional works · 11.3% of its workBiochemistry: 1 fractional works · 3.6% of its workMolecular Medicine: 0 fractional works · 1.6% of its workGenetics: 0 fractional works · 1.4% of its workCancer Research: 0 fractional works · 1.1% of its workClinical Biochemistry: 0 fractional works · 1.0% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 7.4% of its workPharmaceutical Science: 1 fractional works · 4.8% of its workPharmacology: 0 fractional works · 2.6% of its workImmunology and Microbiology: 1 fractional works · 5.6% of its workImmunology: 1 fractional works · 4.6% of its workMicrobiology: 0 fractional works · 1.0% of its workAgricultural and Biological Sciences: 0 fractional works · 2.5% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 1.0% of its workFood Science: 0 fractional works · 0.6% of its workPlant Science: 0 fractional works · 0.5% of its workInsect Science: 0 fractional works · 0.4% of its workNeuroscience: 0 fractional works · 1.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.0% of its workPhysical Sciences: 2 fractional works · 11.9% of its workChemistry: 1 fractional works · 7.3% of its workOrganic Chemistry: 1 fractional works · 6.1% of its workAnalytical Chemistry: 0 fractional works · 0.6% of its workSpectroscopy: 0 fractional works · 0.6% of its workEngineering: 0 fractional works · 2.2% of its workBiomedical Engineering: 0 fractional works · 1.1% of its workElectrical and Electronic Engineering: 0 fractional works · 0.6% of its workAerospace Engineering: 0 fractional works · 0.5% of its workComputer Science: 0 fractional works · 1.1% of its workHardware and Architecture: 0 fractional works · 0.6% of its workArtificial Intelligence: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 0.6% of its workEcology: 0 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 0.6% of its workMaterials Chemistry: 0 fractional works · 0.6% of its workSocial Sciences: 1 fractional works · 5.9% of its workEconomics, Econometrics and Finance: 1 fractional works · 5.9% of its workEconomics and Econometrics: 1 fractional works · 5.9% of its workALL ITS WORKLEO Farmacêuticos(Portugal)17fractional works, all years
Life Sciences36%Physical Sciences12%Health Sciences46%Social Sciences6%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine743.6%
    2. Health Professions01.6%
    3. Nursing00.5%
    1. Biochemistry, Genetics and Molecular Biology320.0%
    2. Pharmacology, Toxicology and Pharmaceutics17.4%
    3. Immunology and Microbiology15.6%
    4. Agricultural and Biological Sciences02.5%
    5. Neuroscience01.0%
    1. Chemistry17.3%
    2. Engineering02.2%
    3. Computer Science01.1%
    4. Environmental Science00.6%
    5. Materials Science00.6%
    1. Economics, Econometrics and Finance15.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.00× its world share, 0 worksAgricultural and Bio…Immunology and Microbiology: 9.46× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 27.02× its world share, 0 worksPharmacology, Toxico…Environmental Science: 1.92× its world share, 0 worksEnvironmental ScienceHealth Professions: 9.04× its world share, 0 worksHealth ProfessionsMedicine: 1.24× its world share, 0 worksMedicineEconomics, Econometrics and Finance: 6.68× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 27.0×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics27.02×0 works
  2. Immunology and Microbiology9.46×0 works
  3. Health Professions9.04×0 works
  4. Economics, Econometrics and Finance6.68×0 works
  5. Agricultural and Biological Sciences2.00×0 works
  6. Environmental Science1.92×0 works
  7. Medicine1.24×0 works

What are the most cited papers from LEO Farmacêuticos (Portugal)?

The most cited paper from LEO Farmacêuticos (Portugal) is "A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism" (Gérald Simonneau, Hervé Sors, Bernard Charbonnier et al., 1997), with 786 citations. Next come "Guidelines on sodium lauryl sulfate (SLS) exposure tests" (260) and "Fusidic Acid: a New Antibiotic" (219).

Most cited papers
#PaperReleasedCitations
1 A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism Gérald Simonneau, Hervé Sors, Bernard Charbonnier et al. · New England Journal of Medicine Open access 4 Sep 1997 786
2 Guidelines on sodium lauryl sulfate (SLS) exposure tests Ron A. Tupker, Carolyn M. Willis, E. Berardksca et al. · Contact Dermatitis Aug 1997 260
3 Fusidic Acid: a New Antibiotic W. O. Godtfredsen, S. JAHNSEN, H. Lorck et al. · Nature 10 Mar 1962 219
4 A New Calcipotriol/Betamethasone Dipropionate Formulation (DaivobetTM) Is an Effective Once-Daily Treatment for Psoriasis vulgaris Roland Kaufmann, Adrian Bibby, Robert Bissonnette et al. · Dermatology 2002 164
5 Synthesis of mc 903, a biologically active vitamin D metabolite analogue Martin J. Calverley · Tetrahedron 1987 158
All 47 most cited papers, with filters and sorting

Which research topics does LEO Farmacêuticos (Portugal) publish most on?

By volume in 2022-now: Health Systems, Economic Evaluations, Quality of Life, Clinical practice guidelines implementation, Health, Medicine and Society and Psoriasis: Treatment and Pathogenesis.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  2. 2 Clinical practice guidelines implementation Public Health, Environmental and Occupational Health 0 works
  3. 3 Health, Medicine and Society General Health Professions 0 works
  4. 4 Psoriasis: Treatment and Pathogenesis Immunology 0 works
  5. 5 Dermatology and Skin Diseases Dermatology 0 works
  6. 6 Drug-Induced Hepatotoxicity and Protection Pharmacology 0 works
  7. 7 Animal Ecology and Behavior Studies Ecology 0 works
  8. 8 Essential Oils and Antimicrobial Activity Food Science 0 works
  9. 9 Therapeutic Uses of Natural Elements Complementary and Manual Therapy 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.6%not open69.4%

World: 40% of research is openly available.

with international co-authors42.3%domestic only57.7%

World: 18% is written across borders.

How has LEO Farmacêuticos (Portugal)'s research output changed?

Output in 2022-2025 was 13% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is LEO Farmacêuticos (Portugal) as a percentage of every work published that year, 0.0000060% in 2024.

still counting0.00010%0.00020%0.00030%LEO Farmacêuticos (Portugal)0.0000056% in 202519801990200020102020

Fractional works of LEO Farmacêuticos (Portugal) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lisbon

All research institutions in Lisbon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about LEO Farmacêuticos (Portugal). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.